Rituximab in Thrombotic Thrombocytopenic Purpura: Medical and Financial Benefits
Acta Haematol
.
2015;134(3):168-9.
doi: 10.1159/000381413.
Epub 2015 May 20.
Author
Marie Scully
1
Affiliation
1
Department of Haematology, University College of London Hospitals, London, UK.
PMID:
25997593
DOI:
10.1159/000381413
No abstract available
Publication types
Editorial
Comment
MeSH terms
Female
Humans
Male
Purpura, Thrombotic Thrombocytopenic / drug therapy*
Rituximab / therapeutic use*
Substances
Rituximab
Grants and funding
FS/10/013/28073/BHF_/British Heart Foundation/United Kingdom
G0800671/MRC_/Medical Research Council/United Kingdom